Nitric oxide and airways

Pulmonary Pharmacology and Therapeutics

Volumn 11, Issue 5-6, 1998, Pages 341-348

  Matera, Maria Gabriella ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIOPTERIN; BRONCHODILATING AGENT; ENZYME ACTIVATOR; FLAVOPROTEIN; GLYCERYL TRINITRATE; METHOTREXATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AIRWAY; ANIMAL TISSUE; ASTHMA; BRONCHODILATATION; BRONCHODILATING ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; GENE LOCATION; HOST RESISTANCE; HUMAN; HUMAN TISSUE; LUNG BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032193163     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1999.0173     Document Type: Conference Paper

References (78)

1. 1. Palmer R M J, Ferrige A G, Moncada S. Nitric oxide release accounts for the obligatory activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
2. 2. Ignarro L J, Buga G M, Wood K S, Byrns R E, Chadhuri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
3. 3. Palmer R M J, Rees D D, Asthon D S, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-1256.
4. 4. Sakum I, Stuehr D J, Gross S S, Nathan C, Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 8664-8667.
5. 5. Bredt D S, Snyder S H. Isolation of nitric oxide sinthase, a calmodulin requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-685.
6. 6. Cho H J, Xie Q W, Calaycay J, Mumford R A, Swiderek K M, Lee T D, Nathan C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 1992; 176: 599-604.
7. 7. Knowles R G, Moncada S. Nitric oxide synthase in mammals. Biochem J 1994; 298: 249-258.
8. 8. Marletta M A. Nitric oxide synthase structure mechanism. J Biol Chem 1993; 268: 1231-1234.
9. 9. Ignarro L J. Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins. Semin Hematol 1989; 26: 63-76.
10. 10. Waldman S A, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclic GMP system. J Cardiovasc Pharmacol 1988; 12: S115-S118.
11. 11. Ignaro L J. Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism. Blood Vessels 1991; 28: 67-73.
12. 12. Moncada S, Palmer R M J, Higgs E A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
13. 13. Snyder S H, Bredt D S. Biological roles of nitric oxide. Sci Am 1992; 266: 68-77.
14. 14. Rees D D, Palmer R J M, Schulz R, Hodson H, Moncada S. Characterisation of the three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
15. 15. Radomoski M W, Palmer R M J, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the consitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-10049.
16. 16. Ding A, Nathan C F, Gracar J, Derynck R, Stuehr D J, Spimal S. Macrophages deactivating factor and transforming growth factors, β-1, β-2 and β-3 inhibit induction of macrophage nitrogen oxide synthesis by interferon-gamma. J Immunol 1990; 145: 490-494.
17. 17. Ignarro L J, Lippton H, Edwards J C, Baricos W H, Hyman A L, Kadowitz P J, Gruetter C A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-749.
18. 18. Keaney J F Jr, Simon D I, Stamler J S, Jaraki O, Scharfstein J, Vita J A, Loscalzo J. NO forms an adduct with serum albumin that has endothelium derived relaxing factor-like properties. J Clin Invest 1993; 91: 1582-1589.
19. 19. Stuart-Smith K, Warner D O, Jones K A. The role of GMP in the relaxation to nitric oxide donors in airway smooth muscle. Eur J Pharmacol 1998; 341: 225-233.
20. 20. Cachofeiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 1992; 19: 138-145.
21. 21. Wiklund N P, Persson M G, Gustafsson L E, Moncada S, Hedqvist P. Modulatory role of endogenous nitric oxide in pulmonary circulation and hypoxic pressor responses in vivo. Eur J Pharmacol 1990; 185: 123-124.
22. 22. Liu S F, Crawley D E, Barnes P J, Evans T W. Endothelium-derived nitric oxide inhibits pulmonary vasoconstriction in isolated blood perfused rat lungs. Am Rev Respir Dis 1991; 143: 32-37.
23. 23. Frostell C, Fratacci M D, Wain J C, Jones R, Zapol W M. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
24. 24. Stamler J S, Loh E, Roddy M, Currie K E, Creager M A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in humans. Circulation 1994; 93: 266-271.
25. 25. Cremona G, Higenbottam T, Borland C, Mist B. Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity. Q J Med 1994; 84: 547-551.
26. 26. Katayama Y, Higenbottam T W, Diaz de Atauri M J, Cremona G, Akamine S, Barbera J A, Rodriguez-Roisin R. Inhaled nitric oxide and arterial oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension. Thorax 1997; 52: 120-124.
27. 27. Barnes P J. Nitric oxide and airways. Eur Respir J 1993; 6: 163-165.
28. 28. Zapol W M, Rimar S, Gillis N, Marletta M, Bosken C H. Nitric oxide and the lung. Am J Respir Crit Care Med 1994; 149: 1375-1380.
29. 29. Gaston B, Drazen J M, Loscalzo J, Stamler J. The biology of nitrogen oxide in the airways. Am J Respir Crit Care Med 1994; 149: 538-551.
30. 30. Al-Ali M K, Howarth P H. Nitric oxide and the respiratory system in health and disease. Thorax 1998; 92: 701-715.
31. 31. Dupuy P M, Shore S A, Drazen J M, Frostell C, Hill W A, Zapoli W M. Bronchodilator action of inhaled NO in guinea pigs. J Clin Invest 1992; 90: 421-428.
32. 32. Hogman M, Frostell C, Amberg H, Hedenstierna G. Inhalation of NO modulates methacholine-induce bronchoconstriction by inhaled nitric oxide: histamine versus methacholine. Am J Respir Crit Care Med 1994; 150: 233-237.
33. 33. Brown R Hey, Zerhouni E A, Hirschman C A. Reversal of bronchoconstriction by inhaled nitric oxide: histamine versus methacholine. Am J Respir Crit Care Med 1994; 150: 233-237.
34. 34. Putensen C, Rasanen J, Lopez F A. Improvement of VA/Q distribution during inhalation of nitric oxide in pigs with methocholine-induce bronchoconstriction. Am J Respir Crit Care Med 1995; 151: 116-122.
35. 35. Nijkamp F P, van der Linde H J, Folkerts J. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am J Respir Dis 1993; 148: 727-734.
36. 36. de Rada O D, Villaro A C, Montuenga L M, Martinez A, Springall D R, Polak J M. Nitric oxide synthase-immunoreactivity neurones in human and porcine respiratory tract. Neurosci Lett 1993; 162: 121-124.
37. 37. Fischer A, Hoffmann B. Nitric oxide synthase in neurones and nerve fibers of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides. Am J Respir Crit Care Med 1996; 154: 209-216.
38. 38. Richardson J B. Nerve supply to the lung. Am Rev Respir Dis 1979; 119: 785-802.
39. 39. Barnes P J. Neural control of human airways in health and disease. Am J Respir Dis 1986; 134: 1289-1314.
40. 40. Richardson J, Beland J. Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol 1976; 41: 764-771.
41. 41. Altiere R J. Neural control in relaxation in cat airways smooth muscle. J Appl Physiol 1984; 57: 1536-1544.
42. 42. Taylor S M, Pare P D, Schellenberg R R. Cholinergic and nonadrenergic mechanisms in human and guinea pig airways. J Appl Physiol 1984; 56: 958-965.
43. 43. Ward J K, Belvisi M G, Fox A J, Miura M, Tadjkarimi S, Yacoub M H, Barnes P J. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airway in vitro. J Clin Invest 1993; 92: 736-743.
44. 44. Belvisi M G, Stretton D, Barnes P J. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways. Eur J Pharmacol 1991; 198: 219-221.
45. 45. Vanhoutte P M. Epithelium-derived relaxing factor(s) and bronchial reactivity. Am Rev Respir Dis 1988; S24-S30.
46. 46. Asano K, Chee C B E, Gaston B, Lilly C M, Gerard C, Drazen J M, Stamler J S. Constitutive and inducible nitric oxide synthase expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91: 10089-10093.
47. 47. Matera M G, D'Agostino B, Cardone M, Calderaro V, Rossi F. Functional role of nitric oxide in guinea pig tracheal epithelium. Life Sci 1995; 56: PL 231-235.
48. 48. Figini M, Ricciardolo F L, Javdan P, Nijkamp F P, Emanueli C, Pradelles P, Folkerts G, Geppetti P. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. Am J Respir Crit Care Med 1996; 153: 918-923.
49. 49. D'Agostino B, Matera M G, Amorena M, Marabese I, Lucisano A, Rossi F. Nitric oxide regulatory role in sensitized guinea pig trachea. Life Sci 1997; 60: PL 353-357.
50. 50. Dupuy P M, Shore S A, Drazen J M, Frostell C, Hill W A, Zapol W M. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992; 90: 421-428.
51. 51. Gwyn D R, Lindeman K S, Hirshman C A. Inhaled nitric oxide attenuates bronchoconstriction in canine peripheral airways. Am J Respir Crit Car Med 1996; 153: 604-609.
52. 52. Hullks G, Warren P M, Douglas N J. The effect of inhaled nitric oxide on brochondilator tone in the normal human airway. Am Rev Respir Dis 1993; 147: A287.
53. 53. Hogman M, Frostell G G, Hedenstrom H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993; 148: 1474-1478.
54. 54. Sapienza M A, Kharitonov S A, Horvath I, Chung K F, Barnes P J. Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 1998; 53: 172-175.
55. 55. Gustafsson L E, Leone A M, Persson M G, Wiklund N P, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-857.
56. 56. Kharitonov S A, Yates D, Robbins R A, Logan-Sinclair R, Shinebourna E A, Barnes P J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 146-147.
57. 57. Belvisi G M, Barnes P J, Larkin S, Yacoub M, Tadjkarimi S, Williams T J, Mitchell J A. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol 1995; 283: 255-258.
58. 58. Kharitonov S A, Wells A J, O'Connor B J, Hansell D M, Logan-Sinclair R, Barnes P J. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Resp Crit Care Med 1995; 151: 1889-1893.
59. 59. Kharitonov S A, Yates D H, Chung K F, Barnes P J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9: 800-803.
60. 60. Garnier P, Fajac I, Dessanges J F, Dall'Ava-Santucci J, Lockart A, Dinh-Xuan A T. Exhaled nitric oxide during acute changes of airways calibre in asthma. Eur Respir J 1996; 9: 1134-1138.
61. 61. Kharitonov S A, O'Connor B J, Evans D J, Barnes P J. Allergen-induced late asthmatic reactions are associated with elevation of exhaled NO. Am J Respir Crit Care Med 1995; 151: 1894-1899.
62. 62. Gustafsson L E. Exhaled nitric oxide as a marker in asthma. Eur Respir J 1998; S49-S52.
63. 63. Schuiling M, Zuidhof A B, Bonouvrie M A, Venema N, Zaagsma J, Meurs H. Role of nitric oxide in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea-pigs. Br J Pharmacol 1998; 123: 1450-1456.
64. 64. Taylor D A, McGrath J L, O'Connor B J, Barnes P J. Allergen-induced early and late responses are not affected by inhibition of endogenous nitric oxide. Am J Respir Crit Care Med 1998; 158: 99-106.
65. 65. Jatakanon A, Lim S, Kharitonov S A, Chung K F, Barnes P J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91-95.
66. 66. Massarro A F, Mehta S, Lilly C M, Kobzik L, Reilly J J, Drazen J M. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996; 153: 1510-1514.
67. 67. Persson M G, Wiklund N P, Gustafsson L E. Endogenous nitric oxide in single exhalation and the change during exercise. Am Rev Respir Dis 1993; 148: 1220-1224.
68. 68. Cremona G, Higenbottam T, Takao M, Hall L, Bower E A. Exhaled nitric oxide in isolated pig lungs. J Appl Physiol 1995; 78: 59-63.
69. 69. Husain M, Adrie C, Ichinose F, Kavosi M, Zapol W M. Exhaled nitric oxide as a marker for organic nitrate tolerance. Circulation 1994; 89: 2498-2502.
70. 70. De Gouw H W, Hendriks J, Woltman M, Twiss I M, Sterk P J. Exhaled nitric oxide is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med 1998; 158: 315-319.
71. 71. Corne J M, Lau L C K, Scott S, Davies R, Friend E, Howarth P H. Nitric oxide levels during upper respiratory tract infection. Am J Respir Crit Care Med 1996; 153: A259.
72. 72. Reiss C S, Komatsu T. Does nitric oxide play a critical role in viral infections? J Virol 1998; 72: 4547-4551.
73. 73. De Gouw H W, Grunberg K, Schot R, Kroes A C, Dick E C, Sterk P J. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1988; 11: 126-123.
74. 74. Vane J R, Mitchell J A, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby D A. Inducible isoforms of cyclo-oxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 1994; 91: 2046-2048.
75. 75. Kageyama N, Miura M, Ichinose M, Tomaki M, Ishikawa J, Ohuchi Y, Endoh N, Shirato K. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. Eur Respir J 1997; 10: 13-19.
76. 76. Bernareggi M, Mitchell J A, Barnes P J, Belvisi M G. Dual action of nitric oxide on airway plasma leakage. Am J Respir Crit Care Med 1997; 155: 869-874.
77. 77. Royall J A, Kooy N W, Beckman J S. Nitric oxide-related oxidants in acute lung injury. New Horizons 1995; 3: 113-122.
78. 78. Barnes P J. Autonomic pharmacology of the airways. In: Chung K F, Barnes P J, eds. Pharmacology of the Respiratory Tract. Experimental and Clinical Research. New York: Marcel Dekker, 1993; 415-455.